The departure of Scott Gottlieb from the U.S. Food and Drug Administration on Tuesday is a potential blow to Silicon Valley.
With Gottlieb departing, Kocher and others at the intersection of health and technology will have to wait and see if the Trump administration changes course.
“This administration has been generally pretty friendly to the private sector in encouraging competition,” Kocher said. “So I would assume that there will be others in the agency who will remain highly engaged with Silicon Valley.”
WATCH: FDA’s Scott Gottlieb is resigning